![Jie Liu D'Elia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jie Liu D'Elia
Amministratore Delegato presso Systimmune, Inc.
Profilo
Jie Liu D'Elia is currently the Chief Executive Officer at Systimmune, Inc. Prior to this, she held positions at AstraZeneca PLC as Director-Business Development, MDRNA, Inc. as Senior Manager, Allozyne, Inc. as Vice President-Business Development & Licensing, Simcere Pharmaceutical Group Ltd.
as Head-Investor Relations, and Baxter Healthcare Ltd.
as Principal.
Dr. D'Elia's education includes an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from Tianjin University, and a doctorate from The University of Texas at Austin.
Posizioni attive di Jie Liu D'Elia
Società | Posizione | Inizio |
---|---|---|
Systimmune, Inc.
![]() Systimmune, Inc. Pharmaceuticals: MajorHealth Technology Systimmune, Inc. operates as a biopharmaceutical company. It develops antibody therapies in oncology. The company was founded in 2014 and is headquartered in Redmond, WA. | Amministratore Delegato | 22/04/2024 |
Precedenti posizioni note di Jie Liu D'Elia
Società | Posizione | Fine |
---|---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Contatto Relazioni con gli Investitori | - |
Baxter Healthcare Ltd.
![]() Baxter Healthcare Ltd. Medical/Nursing ServicesHealth Services Baxter Healthcare Ltd. provides health care services. The firm offers medical products and services for people immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company was founded in 1980 and is headquartered in Auckland, New Zealand. | Corporate Officer/Principal | - |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Corporate Officer/Principal | - |
Allozyne, Inc.
![]() Allozyne, Inc. Medical SpecialtiesHealth Technology Allozyne, Inc. operates as a biotechnology company that develops and manufactures pharmaceutical products. The firm focuses on manufacture of protein therapeutics for the medical need in autoimmune diseases and cancer. The company was founded by David A. Tirrell, Deepshikha Datta, and William A. Goddard, III in March 2004 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Jie Liu D'Elia
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Tianjin University | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
Aziende private | 4 |
---|---|
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Allozyne, Inc.
![]() Allozyne, Inc. Medical SpecialtiesHealth Technology Allozyne, Inc. operates as a biotechnology company that develops and manufactures pharmaceutical products. The firm focuses on manufacture of protein therapeutics for the medical need in autoimmune diseases and cancer. The company was founded by David A. Tirrell, Deepshikha Datta, and William A. Goddard, III in March 2004 and is headquartered in Seattle, WA. | Health Technology |
Baxter Healthcare Ltd.
![]() Baxter Healthcare Ltd. Medical/Nursing ServicesHealth Services Baxter Healthcare Ltd. provides health care services. The firm offers medical products and services for people immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company was founded in 1980 and is headquartered in Auckland, New Zealand. | Health Services |
Systimmune, Inc.
![]() Systimmune, Inc. Pharmaceuticals: MajorHealth Technology Systimmune, Inc. operates as a biopharmaceutical company. It develops antibody therapies in oncology. The company was founded in 2014 and is headquartered in Redmond, WA. | Health Technology |
- Borsa valori
- Insiders
- Jie Liu D'Elia